Clinical trials
Fever clinical trials
Below are recruiting fever clinical trials, each written for real people, not researchers. We’re tracking 83 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06447337Recruiting
Continuous body temperature monitoring trial
This trial tests a wearable device that continuously measures your body temperature while you are in the hospital. It may help doctors track fever or temperature changes caused by infections or other illnesses.
Belgrade, Other/Not ApplicableAges 18 years+ - NCT05965128Recruiting
Testing a new 3-step diagnosis for fever and lung infections
This study tests a new, step-by-step way doctors identify what’s causing sudden fever and respiratory infections (like pneumonia or flu-like illness). It may help clinicians diagnose faster and choose the right next care.
Lanzhou, GansuAges 12–100 - NCT07004751Recruiting
Finding the cause of fever in Nepal
This study is trying to find the cause of fevers that last from 3 to 21 days in people who are admitted to the hospital. It may help doctors better understand and treat fevers in Nepal.
Lalitpur, BagmatiAges 16 years+ - NCT07158814RecruitingPhase 4
Testing the safety of an RSV antibody in infants
This study checks if it is safe to delay the RSV preventive antibody shot by up to two weeks in infants who are getting their routine vaccines. Your baby will get the antibody at a second visit.
Oakland, CaliforniaAges 1 month–7 months - NCT06910631Recruiting
Using a finger-prick test to guide fever care in children
This study tests whether a quick finger-prick test that measures C-reactive protein (CRP) can help doctors decide when a feverish child needs antibiotics or further care. It aims to improve how fever is managed in primary care settings.
AgdeAges 3 months–15 years - NCT07231770Recruiting
Sulfamethoxazole prevention study after kidney transplant
This trial tests how long kidney transplant patients should take a common antibiotic (sulfamethoxazole) to prevent a lung infection called PJP. You may join if you are between 18 and 70 and have had a kidney transplant.
Hefei, AnhuiAges 18 years+ - NCT07739004Recruiting
Fever in Children: Predictors of Serious Illness
This study looks at children with fever to find early signs that might predict serious illness, helping doctors make better triage decisions in the emergency room.
Kayseri, TalasAges birth–18 years - NCT04597437RecruitingPhase 2
Zanamivir for dengue that causes warning signs
This Phase 2 study tests whether zanamivir given through a vein can improve outcomes in people with dengue infection who have warning signs. It may help by reducing the body problems dengue can cause in blood vessels and fluid balance.
Barranquilla, AtlánticoAges 7 years+ - NCT06006559RecruitingPhase 2
Testing a new dengue treatment (EYU688) in adults
This trial tests a new experimental drug, EYU688, for adults with dengue fever. It aims to see if the drug is safe and effective. You may qualify if you have early dengue symptoms, have tested positive for dengue, and are otherwise healthy.
Manaus, AmazonasAges 18–60 - NCT04020536Recruiting
Real-world study for several infectious diseases
This study follows people with confirmed brucellosis, epidemic hemorrhagic fever, or kala-azar (visceral leishmaniasis) to understand how these infections behave in real life. It may help improve care by collecting evidence on diagnosis and treatment outcomes.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT04140578RecruitingPhase 4
Antibiotic prevention for certain liver disease patients
This trial tests whether taking preventive antibiotics can help people with certain liver conditions avoid infections after an endoscopy-related procedure. It may reduce infection risk, but it also requires that you have no signs of infection and haven’t recently taken antibiotics.
TaipeiAges 20–85 - NCT04270786Recruiting
De-escalating antibiotics early for neutropenic fever
This study looks at whether doctors can safely use fewer/less intense antibiotics after fever improves in adults with low white blood cell counts after a stem cell transplant. It may help reduce unnecessary antibiotic exposure while still treating serious infections.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT04323904Recruiting
Hantavirus registry for people with kidney or lung symptoms
This study is a registry, meaning it collects health information and possibly test results from people who have evidence of hantavirus infection along with specific illness symptoms. It may help researchers better understand how hantavirus affects the kidneys or the heart/lungs (and how to recognize it).
Cologne, North-Rhine WestfaliaAges Any age - NCT04494074Recruiting
Cooling fever in ventilated people with septic shock
This study tests whether external cooling can safely lower very high fever in people who are on a breathing machine for septic shock. It may help improve outcomes by controlling fever while they are treated for the infection causing their illness.
AmiensAges 18 years+ - NCT06207942Recruiting
Extended follow-up for cardiac arrest survivors and caregivers
This study follows up on survivors of out-of-hospital cardiac arrest who were already in the STEPCARE trial. It also looks at the well-being of their main caregiver (like a family member or close friend) to see how everyone is doing over time.
BrisbaneAges 18 years+ - NCT06259006RecruitingPhase 3
Early Dexamethasone for Sydenham's Chorea in Children
This trial tests whether a short course of dexamethasone (a steroid tablet) can help children with Sydenham's chorea (movement tics after a strep infection) recover faster. The goal is to see if early treatment improves symptoms and reduces side effects compared to other treatments.
Darwin, Northern TerritoriesAges 4–17 - NCT06336733RecruitingPhase 3
Trial of anakinra for FMF attacks in patients who refuse daily shots
This trial tests if taking anakinra (a targeted medicine) only when you have a painful FMF attack can help, instead of taking it every day. It is for people with Familial Mediterranean Fever (FMF) whose attacks continue despite taking colchicine, and who do not want daily injections.
ParisAges 6 years+ - NCT06338891Recruiting
Can gluten or wheat trigger FMF attacks?
This trial looks at whether foods like gluten or wheat might cause attacks in people with Familial Mediterranean Fever (FMF). If you have FMF, joining could help understand if changing your diet can prevent attacks.
Palermo, SicilyAges 6 months–80 years - NCT06539325Recruiting
Rapid testing for fever after travel to the tropics
This trial uses a rapid test to find the cause of fever in people who recently returned from tropical areas. It aims to detect new or unusual infections early, when you are still in the emergency department.
Paris, ParisAges 18–99 - NCT06579755RecruitingPhase 3
Dengue vaccine study for adults aged 45 to 79
This study tests a dengue vaccine (TDV) in adults aged 45 to 79. It aims to see if the vaccine is safe and effective, even for people with common health conditions like diabetes or high blood pressure.
Buenos AiresAges 45–79 - NCT06618989Recruiting
Predicting serious bacterial infection in febrile infants
This trial is testing a new blood test to help doctors tell which babies under three months with fever are at risk for a serious bacterial infection. If successful, it could help avoid unnecessary antibiotics and hospital stays.
Paris, FranceAges 1 week–3 months - NCT06637904Recruiting
TriVerity blood test for emergency patients with infection
This study tests a new blood test (called TriVerity™) that may help emergency room doctors figure out how sick you are if you have a suspected infection. If you qualify, doctors will check your blood and monitor your recovery through a short phone follow-up.
Peoria, IllinoisAges 18 years+ - NCT06665035RecruitingPhase 3
Dengue vaccine study for infants and toddlers
This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.
Barranquilla, AtlánticoAges 6 months–1.7 years - NCT06718127Recruiting
Study of immune response to yellow fever vaccine
This study looks at how your body's immune system responds to the yellow fever vaccine. It may help researchers understand how well the vaccine protects people.
ParisAges 18–65
Hear when a new Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for fever?
- Yes. Clin2 currently lists 83 recruiting fever studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a fever trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a fever trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.